Schweitzer BI - Search Results

1

Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia.

Lin JT, Tong WP, Trippett TM, Niedzwiecki D, Tao Y, Tan C, Steinherz P, Schweitzer BI, Bertino JR. Lin JT, et al. Among authors: schweitzer bi. Leuk Res. 1991;15(12):1191-6. doi: 10.1016/0145-2126(91)90189-z. Leuk Res. 1991. PMID: 1722550

2

Intrinsic resistance to methotrexate in human soft tissue sarcoma cell lines.

Li WW, Lin JT, Schweitzer BI, Tong WP, Niedzwiecki D, Bertino JR. Li WW, et al. Among authors: schweitzer bi. Cancer Res. 1992 Jul 15;52(14):3908-13. Cancer Res. 1992. PMID: 1377601

3

Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.

Li WW, Lin JT, Schweitzer BI, Bertino JR. Li WW, et al. Among authors: schweitzer bi. Mol Pharmacol. 1991 Nov;40(5):854-8. Mol Pharmacol. 1991. PMID: 1719370

4

Increased activity of gamma-glutamyl hydrolase in human sarcoma cell lines: a novel mechanism of intrinsic resistance to methotrexate (MTX).

Li WW, Waltham M, Tong W, Schweitzer BI, Bertino JR. Li WW, et al. Among authors: schweitzer bi. Adv Exp Med Biol. 1993;338:635-8. doi: 10.1007/978-1-4615-2960-6_131. Adv Exp Med Biol. 1993. PMID: 7508171 No abstract available.

5

Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease.

Göker E, Lin JT, Trippett T, Elisseyeff Y, Tong WP, Niedzwiecki D, Tan C, Steinherz P, Schweitzer BI, Bertino JR. Göker E, et al. Among authors: schweitzer bi. Leukemia. 1993 Jul;7(7):1000-4. Leukemia. 1993. PMID: 7686600

6

Enzymes of the thymidylate cycle as targets for chemotherapeutic agents: mechanisms of resistance.

Bertino JR, Li WW, Lin J, Trippett T, Goker E, Schweitzer B, Banerjee D. Bertino JR, et al. Mt Sinai J Med. 1992 Oct;59(5):391-5. Mt Sinai J Med. 1992. PMID: 1435833 Review.

7

Prediction of antifolate efficacy in a rat sarcoma model.

Li WW, Lin JT, Chang YM, Schweitzer B, Bertino JR. Li WW, et al. Int J Cancer. 1991 Sep 9;49(2):234-8. doi: 10.1002/ijc.2910490216. Int J Cancer. 1991. PMID: 1831805

8

Effect of codon 22 mutations on substrate and inhibitor binding for human dihydrofolate reductase.

Ercikan E, Waltham M, Dicker A, Schweitzer B, Bertino JR. Ercikan E, et al. Adv Exp Med Biol. 1993;338:515-9. doi: 10.1007/978-1-4615-2960-6_104. Adv Exp Med Biol. 1993. PMID: 8304170 No abstract available.

9

Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors.

Li M, Hantzopoulos PA, Banerjee D, Zhao SC, Schweitzer BI, Gilboa E, Bertino JR. Li M, et al. Among authors: schweitzer bi. Hum Gene Ther. 1992 Aug;3(4):381-90. doi: 10.1089/hum.1992.3.4-381. Hum Gene Ther. 1992. PMID: 1525211

10

Dihydrofolate reductase as a therapeutic target.

Schweitzer BI, Dicker AP, Bertino JR. Schweitzer BI, et al. FASEB J. 1990 May;4(8):2441-52. doi: 10.1096/fasebj.4.8.2185970. FASEB J. 1990. PMID: 2185970 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters